Skip to content
10-K

Annual Report

VOLITIONRX LTD VNRX

0001477932-26-001832

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 26, 2026 158.48M sh
Shares Diluted FY 2025 · Dec 31, 2025 106.83M sh
Shares Diluted FY 2025 · Dec 31, 2024 86.53M sh
Capex FY 2025 · Dec 31, 2025 $89.56K
Capex FY 2025 · Dec 31, 2024 $277.5K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$19.68M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$25.89M
Long Term Debt FY 2025 · Dec 31, 2025 $5.82M
Long Term Debt FY 2025 · Dec 31, 2024 $3.95M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.12M
Cash And Equivalents FY 2025 · Dec 31, 2024 $3.26M
Stockholders Equity FY 2025 · Dec 31, 2025 −$34.25M
Stockholders Equity FY 2025 · Dec 31, 2024 −$24.91M
Current Liabilities FY 2025 · Dec 31, 2025 $12.23M
Current Liabilities FY 2025 · Dec 31, 2024 $7.79M
Total Liabilities FY 2025 · Dec 31, 2025 $42.49M
Total Liabilities FY 2025 · Dec 31, 2024 $35.51M
Current Assets FY 2025 · Dec 31, 2025 $2.06M
Current Assets FY 2025 · Dec 31, 2024 $4.06M
Total Assets FY 2025 · Dec 31, 2025 $6.9M
Total Assets FY 2025 · Dec 31, 2024 $9.4M
Sga Expense FY 2025 · Dec 31, 2025 $9.46M
Sga Expense FY 2025 · Dec 31, 2024 $8.49M
Rd Expense FY 2025 · Dec 31, 2025 $10.08M
Rd Expense FY 2025 · Dec 31, 2024 $14.41M
Net Income FY 2025 · Dec 31, 2025 −$23.36M
Net Income restated FY 2025 · Dec 31, 2024 −$26.97M
Operating Income FY 2025 · Dec 31, 2025 −$21.74M
Operating Income FY 2025 · Dec 31, 2024 −$27.02M
Revenue FY 2025 · Dec 31, 2025 $1.73M
Revenue FY 2025 · Dec 31, 2024 $1.23M
Stock Issued FY 2025 · Sep 18, 2025 483.87K sh